|
|
| Maladies Cardiovasculaires > Etude de marché sectorielle |
| Cardioplegia Dollar Volume by Region, 2000-2004 |
|
|
|
|
€ 80,00 |
Editeur
: |
TriMark |
Langue
: |
Anglais |
Date de publication : |
Janvier 2006 |
Taille du document : |
1 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
|
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
Pipeline Insight: Antithrombotics - Anticoagulants and Antiplatelets Have Blockbuster Potential
383 pages | Octobre 2005 |
IntroductionDatamonitor estimates the total revenue generated from new antithrombotics in the seven major markets will reach approximately $10bn by 2015, with novel oral anticoagulants contributing ov |
9 690,00 €
|
| |
| |
Cardiovascular Disease Diagnostics
380 pages | Octobre 2005 |
This report analyzes the worldwide markets for Cardiovascular Disease Diagnostics in Millions of US$.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pa |
3 091,00 €
|
| |
| |
HRT: Major Milestones - Current Perspectives on HRT and Menopause
30 pages | Mars 2005 |
IntroductionThe HRT market peaked in 2001 at $3.5 billion across the seven major markets.
The Women's Health Initiative findings released in 2002 showing that HRT use was associated with an increas |
4 000,00 €
|
| |
| |
The Cardiovascular Outlook 1998-2010
186 pages | Août 1999 |
In 1998, the global cardiovascular market expanded by 7.2%, growing in value from $60bn in 1997 to almost $65bn in 1998.
Market expansion is being driven by expanding prevalent populations in t |
795,00 €
|
| |
| |
The Blockbuster Drugs Outlook: Optimum management strategies throughout the product lifecycle
258 pages | Mai 2001 |
Cost containment pressures have increased the need for pharmaceutical companies to launch innovative, new drugs with sales potentials in excess of $1bn.
In addition to this, companies must ensu |
955,00 €
|
| |
| |
Commercial Insight: Cancer Market Top 20 Drugs - Supportive Care Grows the Cancer Market
92 pages | Janvier 2005 |
IntroductionThe global cancer market is predicted to grow at a CAGR exceeding 10%.
However, a number of global and country-specific factors will support or threaten this trend including epidemiolog |
12 160,00 €
|
| |
| |
Hemoglobin A1c Monitoring
245 pages | Octobre 2005 |
This report analyzes the worldwide markets for Hemoglobin A1c Monitoring in Millions of US$.
The specific product segments analyzed are HbA1c Laboratory Testing, and HbA1c Point of Care Testing & S |
3 091,00 €
|
| |
| |
Stakeholder Insight: Heart Failure - Pumping Up Therapy Will Prevent Failure
125 pages | Juin 2005 |
IntroductionDuring the past two decades, heart failure has emerged as a major chronic disease among the elderly population in the major pharmaceutical markets.
The leading cause of hospitalization |
12 160,00 €
|
| |
| |
UK Market For Fitness Equipment
90 pages | Juillet 2002 |
This report will enable you to:Analyse the size of the UK market for fitness equipment, in value terms, 1997-2006Quantify the size of the UK market for commercial cardiovascular fitness equipment, 1 |
698,00 €
|
| |
| |
Chinese Markets for Cardiovascular Drugs
235 pages | Octobre 2002 |
China's demand for cardiovascular drugs has grown at a fast pace in the past decade.
In the next five years, both production and demand will continue to grow.
This new study examines China's eco |
3 500,00 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
| Cardioplegia Dollar Volume by Region, 2000-2004 |
|
|
This Database Table is a one-page table of hard-to-find numerical information. The Database Table is derived from a proprietary source and is meant to simply provide a high-level overview of specific data points. The Database Table is NOT a report or a comprehensive analysis.
|
|
|
PPLSEN
|
|
|
|
|
